The expanding role of co-trimoxazole in developing countries.

The expanding role of co-trimoxazole in developing countries.

Diğer sürümleri göster (1)

Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in developing countries. Before antiretroviral therapy (ART) scale-up, co-trimoxazole prophylaxis reduced morbidity and mortality in adults and children with HIV by preventing bacterial infections, diarrhoea, mal...

Detaylı Bibliyografya
Asıl Yazarlar:	Church, J, Fitzgerald, F, Walker, A, Gibb, D, Prendergast, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2015

Benzer Materyaller

The expanding role of co-trimoxazole in developing countries.
Yazar:: Church, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Co-trimoxazole for HIV-exposed uninfected infants
Yazar:: Ceri Evans, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Co-trimoxazole prophylaxis in African children with HIV-1 - Reply
Yazar:: Gibb, D, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

CO-TRIMOXAZOLE AND BLOOD
Yazar:: Fleming, A, ve diğerleri
Baskı/Yayın Bilgisi: (1974)

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
Yazar:: Bwakura-Dangarembizi, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Letter: Co-trimoxazole and the blood.
Yazar:: Fleming, A, ve diğerleri
Baskı/Yayın Bilgisi: (1974)

Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
Yazar:: Catherine J. Wedderburn, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy
Yazar:: Eleanor Hutchinson, ve diğerleri

Role of co-trimoxazole in current medical practice
Yazar:: Ekadashi Rajni, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Yazar:: Crook, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Will co-trimoxazole resistance rates ever go down? Resistance rates remain high despite decades of reduced co-trimoxazole consumption
Yazar:: Pouwels, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis
Yazar:: MRH Roushan, ve diğerleri
Baskı/Yayın Bilgisi: (2004-09-01)

Acute polyneuropathy possibily associated with co-trimoxazole.
Yazar:: Grossman, AB, ve diğerleri
Baskı/Yayın Bilgisi: (1977)

Epidermic toxic necrolysis induced by co-trimoxazole
Yazar:: Rolando Rodríguez Hernández, ve diğerleri
Baskı/Yayın Bilgisi: (2016-11-01)

Efficacy of Co-trimoxazol and Rifampine in treatment of childhood Brucellosis
Yazar:: MR Hassanjani Roshan, ve diğerleri
Baskı/Yayın Bilgisi: (2000-10-01)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Yazar:: Walker, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Yazar:: Chintu, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Malaria, sickle cell disease, HIV, and co-trimoxazole prophylaxis: An observational study
Yazar:: Ewurama D.A. Owusu, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
Yazar:: Al AdAwi RM, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Resistance gene pool to co-trimoxazole in non-susceptible Nocardia strains.
Yazar:: Sylvia eValdezate, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Correction to: The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report
Yazar:: Neharika Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

A comparative study on efficacy of Co-trimoxazole and Permethrin for treatment of pediculosis capitis
Yazar:: A.Borghei (MD), ve diğerleri
Baskı/Yayın Bilgisi: (2006-07-01)

Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.
Yazar:: Hasse, B, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
Yazar:: Keragala Arachchige Reshani Kaumada Keragala, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV
Yazar:: Anand A Date, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Comparison of Efficacy of Ciprofloxacin and Co-Trimoxazole in Escherichia Coli Urinary Tract Infection
Yazar:: Muhammad Ayaz, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
Yazar:: Jihad Bishara, ve diğerleri
Baskı/Yayın Bilgisi: (2003-09-01)

A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis.
Yazar:: Rajchanuvong, A, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Co‐Trimoxazole‐Induced Toxic Epidermal Necrolysis: A Case Report From Nepal
Yazar:: Sandesh Gaire, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

A rare case of Co-trimoxazole induced hyperkalemia in a child with acute leukaemia
Yazar:: Richa, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
Yazar:: Basman M. Fadheel
Baskı/Yayın Bilgisi: (2013-04-01)

Comparison of Co-trimoxazole and Cephalexin Efficacy in Preventing Urinary Tract Infection among Children
Yazar:: Jabar Parhiz, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
Yazar:: Zycinska K, ve diğerleri
Baskı/Yayın Bilgisi: (2009-12-01)

Minimal inhibitory concentration of ceftazidime and Co-trimoxazole for Stenotrophomonas maltophilia using E-test
Yazar:: Firoozeh Jamali, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya.
Yazar:: Beatrice Njeri Irungu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.
Yazar:: Christine Manyando, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Can HIV treatments inform other contexts? A trial of an additional indication for co-trimoxazole prophylaxis.
Yazar:: Ngari, M, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Detection of antibodies to co-trimoxazole (preservative drug) interfering with routine red cell antibody screening
Yazar:: Deepti Sachan, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

The Effect of Oral Co-trimoxazole on Decreasing Bacterial Adherence and Biofilm Formation on Ureteral Stents Surfaces
Yazar:: Mohammed S. Abdel-Kader, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

The benefit of co-trimoxazole treatment in the management of acute watery diarrhea caused by invasive bacterial infection
Yazar:: Bobby Setiadi Dharmawan, ve diğerleri
Baskı/Yayın Bilgisi: (2007-07-01)